低分子肝素钙在重症肺源性心脏病心力衰竭患者中的应用效果

目的:探讨低分子肝素钙在重症肺心病心力衰竭患者中的治疗效果。方法:选择120例肺心病心力衰竭患者,上述患者随机分为观察组和对照组。对照组给予常规治疗,观察组在常规治疗基础上给予低分子肝素。观察组两组患者治疗前后血液流变学指标改变情况。结果:观察组治疗后全血黏度、血浆黏度、红细胞压积分别与对照组治疗后比较,差异有统计学意义(P<0.05)。观察组总有效率(96.7%)和对照组总有效率(83.4%)比较,差异有统计学意义(P<0.05)。结论:低分子肝素钙能够改善重症肺心病心力衰竭患者血液流变学指标,治疗效果显著,值得借鉴。

The Application of low molecular heparin calcium on patients with severe pulmonary heart disease and heart failure

Objective To explore the therapeutic effect of low molecular heparin calcium on patients with severe pulmonary heart dis- ease and heart failure. Method 120 cases with severe pulmonary heart disease and heart failure, were selected and randomly divided into observation group and control group. The control group was ~ven conventional treatment, the observation group was given low molecular hep- arin calcium on the basis of the conventional treatment. Blood rheology was observed in two groups of before and after the treatment. Results Tile blood viscosity,plasma viscosity,hematoerit in observation group after treatment compared with those in the control group after treat- ment ,the difference was statistically significant （P 〈 0. 05 ）. Total effective rate of observation group （96. 7% ）compared with that in the control group （ 83.4% ）, the difference was statistically significant （ P 〈 0. 05 ）. Conclusion Low molecular heparin calcium cart improve the blood rheology of the patients with pulmonary heart disease and heart failure,the effect is significant.